Abstract
Cells from patients with ataxia telangiectasia, a rare autosomal recessive disease characterized by primary neuronal degeneration, are abnormally sensitive to the DNA-damaging chemical N-methyl-N'-nitro-N-nitrosoguanidine. We have conducted experiments to determine whether more common primary neuronal degenerations also have a hypersensitivity to this radiomimetic chemical. Fibroblast strains from 13 control donors and from 13 patients with inherited primary neuronal degenerations were treated in vitro with the chemical, and the strains' sensitivity to the chemical was then determined by measuring their ability to divide and form colonies. Twelve of the 13 patient strains, including the 6 Huntington disease and the 4 familial dysautonomia strains, were abnormally sensitive. This hypersensitivity, which is believed to reflect defective repair of the chemically-induced DNA damage, might provide the basis for presymptomatic and prenatal diagnostic tests for these disorders and for elucidating their pathogenesis.
Full text
PDF




Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andrews A. D., Barrett S. F., Robbins J. H. Xeroderma pigmentosum neurological abnormalities correlate with colony-forming ability after ultraviolet radiation. Proc Natl Acad Sci U S A. 1978 Apr;75(4):1984–1988. doi: 10.1073/pnas.75.4.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Arlett C. F., Harcourt S. A. Survey of radiosensitivity in a variety of human cell strains. Cancer Res. 1980 Mar;40(3):926–932. [PubMed] [Google Scholar]
- Arlett C. F. Presymptomatic diagnosis of Huntington's disease? Lancet. 1980 Mar 8;1(8167):540–540. doi: 10.1016/s0140-6736(80)92790-7. [DOI] [PubMed] [Google Scholar]
- Barbeau A. Friedreich's ataxia 1976-an overview. Can J Neurol Sci. 1976 Nov;3(4):389–397. doi: 10.1017/s0317167100025646. [DOI] [PubMed] [Google Scholar]
- Chen P. C., Lavin M. F., Kidson C., Moss D. Identification of ataxia telangiectasia heterozygotes, a cancer prone population. Nature. 1978 Aug 3;274(5670):484–486. doi: 10.1038/274484a0. [DOI] [PubMed] [Google Scholar]
- Jacobs L., Demars R. Quantification of chemical mutagenesis in diploid human fibroblasts: induction of azaguanine-resistant mutants by N-methyl-N'-nitro-N-nitrosoguanidine. Mutat Res. 1978 Feb;53(1):29–53. doi: 10.1016/0165-1161(78)90377-1. [DOI] [PubMed] [Google Scholar]
- Lewis P. D., Corr J. B., Arlett C. F., Harcourt S. A. Increased sensitivity to gamma irradiation of skin fibroblasts in Friedreich's ataxia. Lancet. 1979 Sep 1;2(8140):474–475. doi: 10.1016/s0140-6736(79)91530-7. [DOI] [PubMed] [Google Scholar]
- Moshell A. N., Tarone R. E., Barrett S. F., Robbins J. H. Radiosensitivity in Huntington's disease: implications for pathogenesis and presymptomatic diagnosis. Lancet. 1980 Jan 5;1(8158):9–11. doi: 10.1016/s0140-6736(80)90550-4. [DOI] [PubMed] [Google Scholar]
- Paterson M. C., Anderson A. K., Smith B. P., Smith P. J. Enhanced radiosensitivity of cultured fibroblasts from ataxia telangiectasia heterozygotes manifested by defective colony-forming ability and reduced DNA repair replication after hypoxic gamma-irradiation. Cancer Res. 1979 Sep;39(9):3725–3734. [PubMed] [Google Scholar]
- Robbins J. H., Kraemer K. H., Lutzner M. A., Festoff B. W., Coon H. G. Xeroderma pigmentosum. An inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann Intern Med. 1974 Feb;80(2):221–248. doi: 10.7326/0003-4819-80-2-221. [DOI] [PubMed] [Google Scholar]
- Robbins J. H. Significance of repair of human DNA: evidence from studies of xeroderma pigmentosum. J Natl Cancer Inst. 1978 Sep;61(3):645–656. [PubMed] [Google Scholar]
- SYLVESTER P. E. Some unusual findings in a family with Friedreich's ataxia. Arch Dis Child. 1958 Jun;33(169):217–221. doi: 10.1136/adc.33.169.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scudiero D. A. Decreased DNA repair synthesis and defective colony-forming ability of ataxia telangiectasia fibroblast cell strains treated with N-methyl-N'-nitro-N-nitrosoguanidine. Cancer Res. 1980 Apr;40(4):984–990. [PubMed] [Google Scholar]


